High Concentration mAb Formulations and Their Properties Monoclonal antibodies (mAbs) are the predominant class of recombinant biologic drugs in development, having first emerged as therapeutics in the 1980s. While intravenous (IV) infusion is a commonly-used administration route for mAbs, subcutaneous delivery (sub-C) in doses between 1-1.5 mL is now preferred for patients requiring a frequent dosing regimen […]
The post Are You Maximizing the Recovery of Your mAb? first appeared on World Pharma Today.This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here